Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


28.08.2017

1 Appl Immunohistochem Mol Morphol
7 Bladder Cancer
1 BMC Urol
1 Cancer
1 Cancer Cell Int
2 Cancer Sci
1 Cell Death Dis
1 Clin Genitourin Cancer
1 Cytotherapy
1 Expert Opin Biol Ther
1 Front Endocrinol (Lausanne)
1 Gene
1 Int J Med Sci
2 J Cancer
2 J Clin Oncol
1 J Robot Surg
2 J Urol
1 Medicine (Baltimore)
1 Methods Mol Biol
1 Minerva Urol Nefrol
1 Nat Med
2 Sci Rep
1 Theranostics
1 Urol Oncol
1 Urologe A
1 Urology
1 Vet Comp Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Appl Immunohistochem Mol Morphol

  1. HANLEY KZ, Cohen C, Osunkoya AO
    Hepatocyte Nuclear Factor-1beta Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall.
    Appl Immunohistochem Mol Morphol. 2017;25:134-138.
    PubMed     Text format     Abstract available


    Bladder Cancer

  2. LI R, Sylvester R, Dinney CP, Kamat AM, et al
    Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease.
    Bladder Cancer. 2017;3:147-148.
    PubMed     Text format    

  3. YANG X, Su LJ, La Rosa FG, Smith EE, et al
    The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model.
    Bladder Cancer. 2017;3:201-210.
    PubMed     Text format     Abstract available

  4. KATES M, Chappidi MR, Brant A, Milbar N, et al
    High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.
    Bladder Cancer. 2017;3:191-199.
    PubMed     Text format     Abstract available

  5. SUI W, Lim EA, Joel Decastro G, McKiernan JM, et al
    Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy.
    Bladder Cancer. 2017;3:181-189.
    PubMed     Text format     Abstract available

  6. BREYER J, Shalekenov S, Aziz A, van Rhijn BWG, et al
    Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer.
    Bladder Cancer. 2017;3:173-180.
    PubMed     Text format     Abstract available

  7. KAMAT AM, Lerner S, Black P, Bellmunt J, et al
    Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer.
    Bladder Cancer. 2017;3:145-146.
    PubMed     Text format    

  8. FLAIG TW, Kamat AM, Hansel D, Ingersoll MA, et al
    Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.
    Bladder Cancer. 2017;3:211-223.
    PubMed     Text format     Abstract available


    BMC Urol

  9. REN H, Tang P, Zhao Q, Ren G, et al
    Symptom clusters and related factors in bladder cancer patients three months after radical cystectomy.
    BMC Urol. 2017;17:65.
    PubMed     Text format     Abstract available


    Cancer

  10. RIMAR KJ, Tran PT, Matulewicz RS, Hussain M, et al
    The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
    Cancer. 2017;123:1912-1924.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  11. LIU J, Duan X
    PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells.
    Cancer Cell Int. 2017;17:76.
    PubMed     Text format     Abstract available


    Cancer Sci

  12. MIYAKE M, Morizawa Y, Hori S, Tatsumi Y, et al
    Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
    Cancer Sci. 2017 Aug 24. doi: 10.1111/cas.13384.
    PubMed     Text format     Abstract available

  13. YUAN GJ, Chen X, Lu J, Feng ZH, et al
    CBX8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway.
    Cancer Sci. 2017 Aug 24. doi: 10.1111/cas.13383.
    PubMed     Text format     Abstract available


    Cell Death Dis

  14. LI J, Xu X, Meng S, Liang Z, et al
    MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
    Cell Death Dis. 2017;8:e3010.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  15. HUO J, Chu Y, Chamie K, Smaldone MC, et al
    Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.
    Clin Genitourin Cancer. 2017 Jul 26. pii: S1558-7673(17)30215.
    PubMed     Text format     Abstract available


    Cytotherapy

  16. HUANG CP, Chen CC, Shyr CR
    The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer.
    Cytotherapy. 2017 Aug 14. pii: S1465-3249(17)30633.
    PubMed     Text format     Abstract available


    Expert Opin Biol Ther

  17. BOEGEMANN M, Aydin AM, Bagrodia A, Krabbe LM, et al
    Prospects and progress of immunotherapy for bladder cancer.
    Expert Opin Biol Ther. 2017 Aug 23:1-15. doi: 10.1080/14712598.2017.1366445.
    PubMed     Text format     Abstract available


    Front Endocrinol (Lausanne)

  18. MIRSAIDI N, Burns MP, McClain SA, Forsyth E, et al
    Enhanced Mortality to Metastatic Bladder Cancer Cell Line MB49 in Vasoactive Intestinal Peptide Gene Knockout Mice.
    Front Endocrinol (Lausanne). 2017;8:162.
    PubMed     Text format     Abstract available


    Gene

  19. WU Z, Wang S, Jiang F, Li Q, et al
    Erratum to "Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer" [Gene 626C (2017) 407-413].
    Gene. 2017 Aug 15. pii: S0378-1119(17)30624-8. doi: 10.1016/j.gene.2017.
    PubMed     Text format    


    Int J Med Sci

  20. PICHLER R, Tulchiner G, Fritz J, Schaefer G, et al
    Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Int J Med Sci. 2017;14:811-819.
    PubMed     Text format     Abstract available


    J Cancer

  21. CAO R, Wang G, Qian K, Chen L, et al
    Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARgamma-SIRT1 feedback loop.
    J Cancer. 2017;8:2282-2295.
    PubMed     Text format     Abstract available

  22. CHEN W, Luo K, Ke Z, Kuai B, et al
    TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling.
    J Cancer. 2017;8:1892-1899.
    PubMed     Text format     Abstract available


    J Clin Oncol

  23. SHORE ND, Boorjian SA, Canter DJ, Ogan K, et al
    Intravesical rAd-IFNalpha/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
    J Clin Oncol. 2017 Aug 23:JCO2017723064. doi: 10.1200/JCO.2017.72.3064.
    PubMed     Text format     Abstract available

  24. BALAR AV
    Immune Checkpoint Blockade in Metastatic Urothelial Cancer.
    J Clin Oncol. 2017;35:2109-2112.
    PubMed     Text format     Abstract available


    J Robot Surg

  25. DILIZIA EM, Sadeghi F
    Surgical and pathological outcomes of robotic-assisted radical cystectomy for bladder cancer in the community setting.
    J Robot Surg. 2017 Aug 23. doi: 10.1007/s11701-017-0740.
    PubMed     Text format     Abstract available


    J Urol

  26. CHANG SS
    Re: New Strategies in Bladder Cancer: A Second Coming for Immunotherapy.
    J Urol. 2017;198:482-483.
    PubMed     Text format    

  27. CHANG SS
    Re: Prediction Model for Recurrence Probabilities after Intravesical Chemotherapy in Patients with Intermediate-Risk Non-Muscle-Invasive Bladder Cancer, Including External Validation.
    J Urol. 2017;198:482-483.
    PubMed     Text format    


    Medicine (Baltimore)

  28. YANG Z, Yang X, Lu X, Gao L, et al
    Primary malignant mesenchymoma of bladder: Case report and review of the literature.
    Medicine (Baltimore). 2017;96:e7579.
    PubMed     Text format     Abstract available


    Methods Mol Biol

  29. LIANG LG, Sheng YF, Zhou S, Inci F, et al
    An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.
    Methods Mol Biol. 2017;1660:355-364.
    PubMed     Text format     Abstract available


    Minerva Urol Nefrol

  30. DAL MORO F, Haber GP, Wiklund P, Canda AE, et al
    Robotic intracorporeal urinary diversion: practical review of current surgical techniques.
    Minerva Urol Nefrol. 2017;69:14-25.
    PubMed     Text format     Abstract available


    Nat Med

  31. RICKMAN DS, Beltran H, Demichelis F, Rubin MA, et al
    Biology and evolution of poorly differentiated neuroendocrine tumors.
    Nat Med. 2017;23:1-10.
    PubMed     Text format     Abstract available


    Sci Rep

  32. PAN Y, Chang T, Marcq G, Liu C, et al
    In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer.
    Sci Rep. 2017;7:9309.
    PubMed     Text format     Abstract available

  33. CHA KH, Hadjiiski L, Chan HP, Weizer AZ, et al
    Bladder Cancer Treatment Response Assessment in CT using Radiomics with Deep-Learning.
    Sci Rep. 2017;7:8738.
    PubMed     Text format     Abstract available


    Theranostics

  34. ZHUANG J, Shen L, Yang L, Huang X, et al
    TGFbeta1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.
    Theranostics. 2017;7:3053-3067.
    PubMed     Text format     Abstract available


    Urol Oncol

  35. MOSSANEN M, Kibel AS, Goldman RH
    Exploring exposure to Agent Orange and increased mortality due to bladder cancer.
    Urol Oncol. 2017 Aug 17. pii: S1078-1439(17)30392.
    PubMed     Text format     Abstract available


    Urologe A

  36. AUTENRIETH ME, Horn T, Kurtz F, Nguyen K, et al
    [Intravesical radioimmunotherapy of carcinoma in situ of the urinary bladder after BCG failure].
    Urologe A. 2017;56:40-43.
    PubMed     Text format     Abstract available


    Urology

  37. MARIAPPAN P, Lavin V, Phua CQ, Khan SAA, et al
    Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers - a Prospective Double-Blind Clinical Study.
    Urology. 2017 Aug 14. pii: S0090-4295(17)30802.
    PubMed     Text format     Abstract available


    Vet Comp Oncol

  38. GUSTAFSON TL, Kitchell BE, Biller B
    Hedgehog signaling is activated in canine transitional cell carcinoma and contributes to cell proliferation and survival.
    Vet Comp Oncol. 2017;15:174-183.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: